| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,722,000 | 4,493,000 | 5,227,000 | 4,622,000 | | Cost of Revenue | 2,832,000 | (1,991,000) | 5,444,000 | 1,519,000 | | | Gross Profit | 1,890,000 | 6,484,000 | (217,000) | 3,103,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 200,000 | 4,747,000 | (2,061,000) | 1,272,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 436,000 | 404,000 | 431,000 | 401,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,254,000 | 1,333,000 | 1,413,000 | 1,430,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (38,000) | (151,000) | (158,000) | (40,000) | | Earnings Before Interest And Taxes | 1,208,000 | 1,175,000 | 1,249,000 | 1,382,000 | | Interest Expense | 187,000 | 194,000 | 202,000 | 215,000 | | Income Before Tax | 1,021,000 | 981,000 | 1,047,000 | 1,167,000 | | Income Tax Expense | 310,000 | 295,000 | 346,000 | 418,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 711,000 | 686,000 | 701,000 | 749,000 | | | Non-recurring Events | | Discontinued Operations | 1,000 | 21,000 |
-
| (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 712,000 | 707,000 | 701,000 | 748,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $712,000 | $707,000 | $701,000 | $748,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
